Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Estradiol Supplement or Induced Hypertension May Attenuate the Angiotensin Ii Type 1 Receptor Antagonist-Promoted Renal Blood Flow Response to Graded Angiotensin Ii Administration in Ovariectomized Rats Publisher Pubmed



Choopani S1, 2 ; Nematbakhsh M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Water & Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: JRAAS - Journal of the Renin-Angiotensin-Aldosterone System Published:2022


Abstract

Backgrounds. Estrogen replacement therapy (ERT) and hypertension may influence females’ renin-angiotensin system (RAS) and its components. The angiotensin II (Ang II) type 1 receptor (AT1R) antagonist (losartan) may promote renal blood flow (RBF), and it is widely used in the clinic to control hypertension. The main objective of this study was the effects of estradiol or induced hypertension on RBF response to Ang II in losartan-treated ovariectomized (OVX) rats. Methods. Two groups of OVX rats were treated with placebo (group 1) and estradiol (group 2) for period of four weeks, and another group of OVX rats was subjected to induce hypertension by two-kidney one clip (2K1C) model (group 3). All the groups were subjected to the surgical procedure under anesthesia, and AT1R was blocked by losartan. RBF and renal vascular resistance (RVR) responses to Ang II administration were determined and compared. Results. Mean arterial (MAP) and renal perfusion (RPP) pressures in group 3 and uterus weight (UT) in group 2 were significantly more than other groups ((Formula presented.)). Ang II infusion resulted in dose-related percentage change increase in RBF and decrease in RVR. However, these responses in the OVX-estradiol and OVX-hypertensive rats were significantly lower than in the OVX-control group ((Formula presented.)). For instance, at the dose of 1000 ng/kg/min of Ang II administration, the percentage change of RBF was (Formula presented.), (Formula presented.), and (Formula presented.) in the groups of 1 to 3, respectively. Conclusion. Losartan prescription in some conditions such as hypertension or ERT could worsen RBF and RVR responses to Ang II. 2022, SAGE Publications Ltd. All rights reserved.
Experts (# of related papers)
Other Related Docs
30. Renoprotective Impact of Angiotensin 1-7: Is It Certain?, Journal of Nephropathology (2019)
45. Losartan: A Pharmacotherapy in Cardiovascular Disease, New Emirates Medical Journal (2024)
46. Oestrogen Promotes Coronary Angiogenesis Even Under Normoxic Conditions, Basic and Clinical Pharmacology and Toxicology (2008)